AI assistant
Instil Bio, Inc. — Director's Dealing 2024
Jun 13, 2024
33728_dirs_2024-06-13_f8b9c340-bcd5-4bc6-bea3-170945dc3e53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2024-06-13
Reporting Person: Gibson Neil W (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | Stock Option (Right to Buy) | $10.50 | A | 5000 | Acquired | 2034-06-12 | Common Stock (5000) | Direct |
Footnotes
F1: The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).